Researchers hypothesized that tumor-accumulated prostate-specific membrane antigen (PSMA)-nanobubbles combined with low frequency unfocused therapeutic US would lead to selective damage and induce a specific therapeutic effect in PSMA-expressing tumors compared to PSMA-negative tumors.
[Bioactive Materials]